Skip to main content
SpringerLink
Log in

Natural Host Resistance Mechanisms against Systemic Mycotic Agents

  • Chapter
Functions of the Natural Immune System

Abstract

The different fungi responsible for diseases in man are quite diverse in their characteristics. Some fungi are “true” pathogens in that they appear to infect normal individuals, whereas others are opportunistic and establish an infection only in an altered or compromised host. The natural portal of entry into the host varies among the fungi, but they usually fall within two major groups—those that enter by introduction into the skin, and those that enter through the respiratory route. The disease-causing fungi differ in their tissue preferences as well as in their morphological characteristics and size. These various features are important factors and must be considered in a discussion of the effectiveness of the natural host resistance mechanisms in eliminating the mycotic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Emmons, C. W., Binford, C. H., Utz, J. P., and Kwon-Chung, K. J., 1977, Medical Mycology, 3d Ed., Lea and Febiger, Philadelphia.

    Google Scholar 

  2. Rippon, J. W., 1982, Medical Mycology, 2d Ed., W. B. Saunders, Philadelphia.

    Google Scholar 

  3. Drutz, D. J., and Huppert, M., 1983, Coccidioidomycosis: Factors affecting the host-parasite interaction, J. Infect. Dis. 147:372–390.

    PubMed  CAS  Google Scholar 

  4. Schneerson-Porat, S., Shahar, A., and Aronson, M., 1965, Formation of histiocyte rings in response to Cryptococcus neoformansinfection, J. Reticuloendothel. Soc. 2:249–255.

    PubMed  CAS  Google Scholar 

  5. Farkas, V., 1979, Biosynthesis of cell walls of fungi, Microbiol. Rev. 43:117–144.

    PubMed  CAS  Google Scholar 

  6. Bulmer, G. S., and Sans, M. D., 1968, Crypotococcus neoformans. III. Inhibition of phagocytosis, J. Bacteriol. 95:5–8.

    PubMed  CAS  Google Scholar 

  7. Artz, R. P., and Bullock, W. E., 1979, Immunoregulatory responses in experimental disseminated histoplasmosis: Depression of T-cell-dependent and T-effector responses by activation of splenic suppressor cells, Infect. Immun. 23:893–902.

    PubMed  CAS  Google Scholar 

  8. Murphy, J. W., and Moorhead, J. W., 1982, Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen, J. Immunol. 128:276–283.

    PubMed  CAS  Google Scholar 

  9. Rivas, V., and Rogers, T. J., 1983, Studies on the cellular nature of Candida albicans-induced suppression, J. Immunol. 130:376–379.

    PubMed  CAS  Google Scholar 

  10. Cohen, M. S., Isturiz, R. E., Malech, H. L., Root, R. K., Wilfert, C. M., Gutman, L., and Buckley, R. H., 1981, Fungal infection in chronic granulomatous disease, Am J. Med. 71:59–66.

    PubMed  CAS  Google Scholar 

  11. Howard, D. H., 1975, The role of phagocytic mechanisms of defense against Histoplasma capsulatum, in: Mycoses, Pan American Health Organization, Washington, pp. 50–59.

    Google Scholar 

  12. Howard, D. H., 1981, Mechanisms of resistance in the systemic mycoses, Compr. Immuno. 8:475–494.

    Google Scholar 

  13. Diamond, R. D., 1981, Immunology of invasive fungal infections, Compr. Immunol. 8:585–633.

    Google Scholar 

  14. Lehrer, R. I., and Fleishchmann, J., 1982, Antifungal defense by macrophages, in: Microbiology—1982, (D. Schlessinger, ed.), American Society for Microbiology, Washington, pp. 385–387.

    Google Scholar 

  15. Fleishchmann, J., and Lehrer, R. I., 1983, Phagocytic mechanisms in host response, in: Fungi Pathogenic for Humans and Animals, Part B, Pathogenicity and Detection, II (D. Howard, ed.), Marcel Dekker, New York, pp. 123–149.

    Google Scholar 

  16. Diamond, R. D., 1974, Antibody-dependent killing of Cryptococcus neoformans by human peripheral blood mononuclear cells, Nature 247:148–150.

    PubMed  CAS  Google Scholar 

  17. Diamond, R. D., and Allison, A. C., 1976, Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans, Infect. Immun. 14:716–720.

    PubMed  CAS  Google Scholar 

  18. Baccarini, M., Bistoni, F., and Lohmann-Matthes, M., 1985, In vitro natural cell-mediated cytotoxicity against Candida albicans: Macrophage precursors as effector cells, J. Immunol. 134:2658–2665.

    Google Scholar 

  19. Baccarini, M., Kiderlen, A. F., Decker, T., and Lohmann-Matthes, M., 1986, Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrow, Cell. Immunol. 101:339–350.

    PubMed  CAS  Google Scholar 

  20. Decker, T., Lohmann-Matthes, M., and Baccarini, M., 1986. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans, Infect. Immun. 54:477–486.

    PubMed  CAS  Google Scholar 

  21. Decker, T., Baccarini, M., and Lohmann-Mattes, M., 1986, Liver-associated macrophage precursors as natural cytotoxic effectors against Candida albicans and YAC-1 cells, Eur. J. Immunol. 16:693–699.

    PubMed  CAS  Google Scholar 

  22. Baccarini, M., Bistoni, F., and Lohmann-Matthes, M., 1986, Organ-associated macro¬phage precursor activity: Isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice, J. Immunol. 136:837–843.

    PubMed  CAS  Google Scholar 

  23. Diamond, RD., Root, R. K., and Bennett, J. E., 1972, Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro, J. Infect. Dis. 125:367–376.

    PubMed  CAS  Google Scholar 

  24. Diamond, R. D., and Bennett, J. E., 1973, Growth of Cryptococcus neoformanswithin human macrophages in vitro, Infect. Immun. 7:231–236.

    PubMed  CAS  Google Scholar 

  25. Lehrer, R. I., 1970, The fungicidal activity of human monocytes: A myeloperoxidase- linked mechanism, Clin. Res. 18:408.

    Google Scholar 

  26. Lehrer, R. I., 1975, The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms, J. Clin. Invest. 55:338–346.

    PubMed  CAS  Google Scholar 

  27. Brummer, E., and Stevens, D. A., 1982, Opposite effects of human monocytes, macrophages and polymorphonuclear neutrophils on replication of Blastomyces dermatitidis in vitro, Infect. Immun. 36:297–303.

    PubMed  CAS  Google Scholar 

  28. Drutz, DJ., and Frey, CL., 1985, Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts, J. Lab. Clin. Med. 105:737–750.

    PubMed  CAS  Google Scholar 

  29. Bradsher, R. W., Ulmer, W. C., Marmer, D. J., Townsend, J. W., and Jacobs, R. F., 1985, Intracellular growth and phagocytosis of Blastomyces dermatitidisby monocyte-derived macrophages from previously infected and normal subjects, J. Infect. Dis. 151:57–64.

    PubMed  CAS  Google Scholar 

  30. Swenson, F. J., and Kozel, T. R., 1978, Phagocytosis of Cryptococcus neoformansby normal and thioglycolate-activated macrophages, Infect. Immun. 21:714–720.

    PubMed  CAS  Google Scholar 

  31. Lehrer, R. I., Ferrari, L. G., Patterson-Delafield, J., and Sorrell, T., 1980, Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans, Infect. Immun. 28:1001–1008.

    PubMed  CAS  Google Scholar 

  32. Granger, D. L., Perfect, J. R., and Durack, D. T., 1986, Macrophage-mediated fungis-tasis in vitro: Requirements for intracellular and extracellular cytotoxicity, J. Immunol. 136:672–680.

    PubMed  CAS  Google Scholar 

  33. Howard, D. H., and Otto, V., 1977, Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis, Infect. Immun. 16:226–231.

    PubMed  CAS  Google Scholar 

  34. Beaman, L., Benjamini, E., and Pappagianis, D., 1981, Role of lymphocytes in macro phage-induced killing of Coccidioides immitis in vitro. Infect. Immun. 34:347–353.

    PubMed  CAS  Google Scholar 

  35. Wu-Hsieh, B., Zlotnik, A., and Howard, D. H., 1984, T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum, Infect. Immun. 43:380–385.

    PubMed  CAS  Google Scholar 

  36. Wu-Hsieh, B., and Howard, D. H., 1984, Inhibition of growth of Histoplasma capsulatumby lymphokine-stimulated macrophages. J. Immunol. 132:2593–2597.

    PubMed  CAS  Google Scholar 

  37. Brummer, E., Morrison, C. J., and Stevens, D. A., 1985, Recombinant and natural gamma-interferon activation of macrophages in vitro: Different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi, Infect. Immun. 49:724–730.

    PubMed  CAS  Google Scholar 

  38. Sugar, A. M., Brummer, E., and Stevens, D. A., 1986, Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis, J. Med. Microbiol. 21:7–11.

    PubMed  CAS  Google Scholar 

  39. Cohen, A. B., and Cline, M. J., 1971, The human alveolar macrophage: Isolation cultivation in vitro, and studies of morphologic and functional characteristics, J. Clin. Invest. 50:1390–1398.

    PubMed  CAS  Google Scholar 

  40. Peterson, E. M., and Calderone, R. A., 1977, Growth inhibition of Candida albicansby rabbit alveolar macrophages, Infect. Immun. 15:910–915.

    PubMed  CAS  Google Scholar 

  41. Sugar, A. M., Brummer, E., and Stevens, D. A., 1983, Murine pulmonary macrophages: Evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity, Am. Rev. Respir. Dis. 127:110–112.

    PubMed  CAS  Google Scholar 

  42. Beaman, L., and Holmberg, C. A., 1980, In vitro response of alveolar macrophages to infection with Coccidioides immitis, Infect. Immun. 28:594–600.

    PubMed  CAS  Google Scholar 

  43. Bulmer, G. S., and Tacker, J. R., 1975, Phagocytosis of Cryptococcus neoformansby alveolar macrophages, Infect. Immun. 11:73–79.

    PubMed  CAS  Google Scholar 

  44. Sanchez, S. B., and Carbonell, L. M., 1975, Immunological studies on Histoplasma capsulatum, Infect. Immun. 11:387–394.

    PubMed  Google Scholar 

  45. Kimberlin, C. L., Hariri, A. R., Hempel, H. O., and Goodman, N. L., 1981, Interactions between Histoplasma capsulatumand macrophages from normal and treated mice: Comparison of the mycelial and yeast phases in alveolar and peritoneal macrophages, Infect. Immun. 34:6–10.

    PubMed  CAS  Google Scholar 

  46. Waldorf, A. R., Ruderman, N., and Diamond, R. D., 1984, Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus, J. Clin. Invest. 74:150–160.

    PubMed  CAS  Google Scholar 

  47. Waldorf, A. R., Levitz, S. M., and Diamond, R. D., 1984, In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus, J. Infect. Dis. 150:752–760.

    PubMed  CAS  Google Scholar 

  48. Lehrer, R. I., Howard, D. H., Sypherd, P. S., Edwards, J. E., Segal, G. P., and Winston, D. J., 1980, Mucormycosis, Ann. Intern. Med. 93(Part 1):93–108.

    Google Scholar 

  49. Goodwin, R. A., and DesPrez, R. M., 1978, Histoplasmosis, Am. Rev. Respir. Dis. 117:929–955.

    PubMed  Google Scholar 

  50. Wolf, J. E., Kerchberger, V., Kobayashi, G. S., and Little, J. R., 1987, Modulation of the macrophage oxidative burst by Histoplasma capsulatum, J. Immunol. 138: 582–586.

    PubMed  CAS  Google Scholar 

  51. Eissenberg, L. G., and Goldman, W. E., 1987, Histoplasma capsulatum fails to trigger release of superoxide from macrophages, Infect. Immun. 55:29–34.

    PubMed  CAS  Google Scholar 

  52. Peterson, E. M., and Calderone, R. A., 1978, Inhibition of specific amino acid uptake in Candida albicansby lysosomal extracts from rabbit alveolar macrophages, Infect. Immun. 21:506–513.

    PubMed  CAS  Google Scholar 

  53. Lehrer, R. I., Szklarek, D., Selsted, M. E., and Fleischmann, J., 1981, Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant, Infect. Immun. 33:775–778.

    PubMed  CAS  Google Scholar 

  54. Kletter, Y., and Nagler, A., 1984, Function of peripheral blood and bone-marrow monocytes in preleukemic patients: Normal phagocytosis and intracellular killing of Candida albicans, Acta Haematol. 72:379–383.

    PubMed  CAS  Google Scholar 

  55. Schuit, K. E., 1979, Phagocytosis and intracellular killing of pathogenic yeast by human monocytes and neutrophils, Infect. Immun. 24:932–938.

    PubMed  CAS  Google Scholar 

  56. Beaman, L., and Pappagianis, D., 1985, Fate of Coccidioides immitis arthroconidia in human peripheral blood monocyte cultures in vitro, in: Coccidioidomycosis, National Foundation Infectious Diseases, Washington, pp. 170–180.

    Google Scholar 

  57. Diamond, R. D., and Haudenschild, C. C., 1981, Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro, J. Clin. Invest. 67:173–182.

    PubMed  CAS  Google Scholar 

  58. Holland, P., 1971, Circulating human phagocytes and Histoplasma capsulatum, in: Histoplasmosis, Proceedings of the 2d National Conference (L. Ajello, E. W. Chick, and M. L. Furcolow, eds.), Charles C. Thomas, Springfield, IL, pp. 380–383.

    Google Scholar 

  59. Diamond, R. D., Huber, E., and Haudenschild, C. C., 1983, Mechanisms of destruction of Aspergillus fumigatushyphae mediated by human monocytes, J. Infect. Dis. 147:474–483.

    PubMed  CAS  Google Scholar 

  60. Diamond, R. D., Haudenschild, C. C., and Erickson, N. F. Ill, 1982, Monocyte-mediated damage to Rhizopus oryzaehyphae in vitro, Infect. Immun. 38:292–297.

    PubMed  CAS  Google Scholar 

  61. Lehrer, R. I., and Cline, M. J., 1969, Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candidainfection, J. Clin. Invest. 48:1478–1488.

    PubMed  CAS  Google Scholar 

  62. Lehrer, R. I., 1975, The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms, J. Clin. Invest. 55:338–346.

    PubMed  CAS  Google Scholar 

  63. Collins, M. S., and Pappagianis, D., 1974, Inhibition by lysozyme of growth of the spherule phase of Coccidiodes immitis in vitro, Infect. Immun. 10:616–623.

    PubMed  CAS  Google Scholar 

  64. Morgan, M. A., Blackstock, R. A., Bulmer, G. S., and Hall, N. K., 1983, Modification of macrophage phagocytosis in murine crytococcosis, Infect. Immun. 40:493–500.

    PubMed  CAS  Google Scholar 

  65. Blackstock, R. A., McCormack, J. M., and Hall, N. K., 1987, Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance, Infect. Immun. 55:233–239.

    Google Scholar 

  66. Cutler, J. E., 1977, Chemotactic factor produced by Candida albicans, Infect. Immun. 18:568–573.

    PubMed  CAS  Google Scholar 

  67. Weeks, B. A., Escobar, M. R., Hamilton, P. B., and Fueston, V. M., 1976, Chemotaxis of polymorphonuclear neutrophilic leukocytes by mannan-enriched preparations of Candida albicans, Adv. Exp. Med. Biol. 73:161–169.

    PubMed  Google Scholar 

  68. Chinn, R. Y. W., and Diamond, R. D., 1982, Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: Relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis, Infect. Immun. 38:1123–1129.

    PubMed  CAS  Google Scholar 

  69. Thurmond, L. M., and Mitchell, T. G., 1984, Blastomyces dermatitidis chemotactic factor: Kinetics of production and biological characterization evaluated by a modified neutrophil chemotaxis assay, Infect. Immun. 46:87–93.

    PubMed  CAS  Google Scholar 

  70. Ratnoff, W. D., Pepple, J. M., and Winkelstein, J. A., 1980, Activation of the alternative complement pathway by Histoplasma capsulatum, Infect. Immun. 30:147–149.

    PubMed  CAS  Google Scholar 

  71. Galgiani, J. N., Yam, P., Petz, L. D., Willims, P. L., and Stevens, D. A., 1980. Complement activation by Coccidioides immitis: In vitroand clinical studies, Infect. Immun. 28:944–949.

    Google Scholar 

  72. Waldorf, A. R., and Diamond, R. D., 1985, Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzaespores and Aspergillus fumigatusconidia, Infect. Immun. 48:458–463.

    PubMed  CAS  Google Scholar 

  73. Diamond, R. D., May, J. E., Kane, M., Frank, M. M., and Bennett, J. E., 1973, The role of late complement components and the alternate complement pathway in experimental cryptococcosis, Proc. Soc. Exp. Biol. Med. 144:312–315.

    PubMed  CAS  Google Scholar 

  74. Diamond, R. D., May, J. E., Kane, M., Frank, M. M., and Bennett, J. E., 1974, The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformansinfection, J. Immunol. 112:2260–2270.

    PubMed  CAS  Google Scholar 

  75. Diamond, R. D., and Erickson, N. F. III, 1982, Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans, Infect. Immun. 38:380–382.

    PubMed  CAS  Google Scholar 

  76. Laxalt, K. A., and Kozel, T. R., 1979, Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans, Infect. Immun. 26:435–440.

    PubMed  CAS  Google Scholar 

  77. Gadebusch, H. H., 1972, Mechanisms of native and acquired resistance to infection with Cryptococcus neoformans, in: Macrophages and Cellular Immunity (A. Laskin and H. Lechevalier, eds.), CRC Press, Cleveland, OH, pp. 3–12.

    Google Scholar 

  78. Ray, T. L., and Wuepper, K. D., 1976, Activation of the alternative (properdin) pathway of complement by Candida albicansand related species, J. Invest. Dermatol. 67:700–703.

    PubMed  CAS  Google Scholar 

  79. Rhodes, J. C., Wicker, L. S., and Urba, W. J., 1980, Genetic control of susceptibility to Cryptococcus neoformansin mice, Infect. Immun. 29:494–499.

    PubMed  CAS  Google Scholar 

  80. Kozel, R. R., and Pfrommer, G. S. T., 1986, Activation of the complement system by Cryptococcus neoformansleading to binding of iC3b to the yeast, Infect. Immun. 52:1–5.

    PubMed  CAS  Google Scholar 

  81. Sixbey, J. W., Fields, B. T., Sun, C. N., Clark, R. A., and Nolan, C. M., 1979, Interactions between human granulocytes and Blastomyces dermatitidis, Infect. Immun. 23: 41–44.

    PubMed  CAS  Google Scholar 

  82. Lehrer, R. I., and Cline, M. J., 1969, Interaction of Candida albicans with human leukocytes and serum, J. Bacteriol. 98:996–1004.

    PubMed  CAS  Google Scholar 

  83. Goihman-Yahr, M., Essenfeld-Yahr, E., De Albornoz, M., Yarzabal, L., De Gomez, M. H., Martin, B. S., Ocanto, A., Gil, F., and Convit, J., 1980, Defect of in vitrodigestive ability of polymorphonuclear leukocytes in paracoccidioidomycosis, Infect. Immun. 28:557–566.

    PubMed  CAS  Google Scholar 

  84. Diamond, R. D., Krzesicki, R., and Jao, W., 1978, Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro, J. Clin. Invest. 61:349–359.

    PubMed  CAS  Google Scholar 

  85. Tacker, J. R., Farhi, F., and Bulmer, G. S., 1972, Intracellular fate of Cryptococcus neoformans, Infect. Immun. 6:162–167.

    PubMed  CAS  Google Scholar 

  86. Diamond, R. D., Krzesicki, R., Epstein, B., and Jao, W., 1978, Damage to hyphal forms of fungi by human leukocytes in vitro, Am. J. Pathol. 91:313–327.

    PubMed  CAS  Google Scholar 

  87. Diamond, R. D., and Clark, R. A., 1982, Damage to Aspergillus fumigatusand Rhizopus oryzaehyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro, Infect. Immun. 38:487–495.

    PubMed  CAS  Google Scholar 

  88. Levitz, S. M., and Diamond, R. D., 1985, Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro, Infect. Immun. 152:33–42.

    CAS  Google Scholar 

  89. Sugar, A. S., Chahal, R. S., Brummer, E., and Stevens, D. A., 1983, Susceptibility of Blastomyces dermatitidisstrains to products of oxidative metabolism, Infect. Immun. 41:908–912.

    PubMed  CAS  Google Scholar 

  90. Brummer, E., Sugar, A. M., and Stevens, D. A., 1984, Immunological activation of polymorphonuclear neutrophils for fungal killing: Studies with murine cells and Blastomyces dermatitidis in vitro, J. Leuk. Biol. 36:505–520.

    CAS  Google Scholar 

  91. Howard, D. H., 1973, Fate of Histoplasma capsulatumin guinea pig polymorphonuclear leukocytes, Infect. Immun. 8:412–419.

    PubMed  CAS  Google Scholar 

  92. Howard, D. H., 1983, Studies on the catalase of Histoplasma capsulatum, Infect. Immun. 39:1161–1166.

    PubMed  CAS  Google Scholar 

  93. McEwen, J. G., Sugar, A. M., Brummer, E., Restrepo, A., and Stevens, D. A., 1984, Toxic effect of products of oxidative metabolism on the yeast form of Paracoccidioides brasiliensis, J. Med. Microbiol. 18:423–428.

    PubMed  CAS  Google Scholar 

  94. Levitz, S. M., and Diamond, R. D., Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodine cytotoxic system: Comparison with the myeloperoxidase-hydrogen peroxide-halide system, Infect. Immun. 43:1100–1102.

    Google Scholar 

  95. Gadebusch, H. H., and Johnson, A. G., 1966, Natural host resistance to infection with Cryptococcus neoformans. IV. The effect of some cationic proteins on the experimental disease, J. Infect. Dis. 116:551–565.

    PubMed  CAS  Google Scholar 

  96. Kirpatrick, C. H., Green, I., Rich, R. R., and Schade, A. L., 1971, Inhibition of growth of Candida albicansby iron-unsaturated lactoferrin: Relation to host defense mechanisms in chronic mucocutaneous candidiasis, J. Infect. Dis. 124:539–544.

    Google Scholar 

  97. Lehrer, R. I., and Ladra, K. M., Fungicidal components of mammalian granulocytes active against Cryptococcus neoformans, J. Infect. Dis. 136:96–99.

    Google Scholar 

  98. Selsted, M. E., Szklarek, D., and Lehrer, R. I., 1984, Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes, Infect. Immun. 45:150–154.

    PubMed  CAS  Google Scholar 

  99. Selsted, M. E., Szklarek, D., Ganz, T., and Lehrer, R. I., 1985, Activity of rabbit leukocyte peptides against Candida albicans, Infect. Immun. 49:202–206.

    PubMed  CAS  Google Scholar 

  100. Selsted, M. E., Harwig, S. S. L., Ganz, T., Schilling, J. W., and Lehrer, R. I., 1985, Primary structures of three human neutrophil defensins, J. Clin. Invest. 76:1436–1439.

    PubMed  CAS  Google Scholar 

  101. Ganz, T. Selsted, M. E., Szklarek, D., Harwig, S. S. L., and Daher, K., Bainton, D. F., and Lehrer, R. I., 1985, Defensins—natural peptide antibiotics of human neutrophils, J. Clin. Invest. 76:1427–1435.

    PubMed  CAS  Google Scholar 

  102. Segal, G. P., Lehrer, R. I., and Selsted, M. E., 1985, In vitro effect of phagocyte cationic peptides on Coccidioides immitis, J. Infect. Dis. 151:890–894.

    PubMed  CAS  Google Scholar 

  103. Lehrer, R. I., Szklarek, K., Ganz, T., and Selsted, M. E., 1986, Synergistic activity of rabbit granulocyte peptides against Candida albicans, Infect. Immun. 52:902–904.

    PubMed  CAS  Google Scholar 

  104. Diamond, R. D., Oppenheim, F., Nakagawa, Y., Krzesicki, R., and Haudenschild, C., 1980, Properties of a product of Candida albicanshyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro, J. Immunol. 125:2797–2804.

    PubMed  CAS  Google Scholar 

  105. Kozel, T. R., Highison, B., and Stratton, J., 1984, Localization on encapsulated Cryptococcus neoformansof serum components opsonic for phagocytosis by macrophages and neutrophils, Infect. Immun. 43:574–579.

    PubMed  CAS  Google Scholar 

  106. Kalina, M., Kletter, Y., Shahar, A., and Aronson, M., 1971, Acid phosphatase release from intact phagocytic cells surrounding a large-sized parasite, Proc. Soc. Exp. Biol. Med. 136:407–410.

    PubMed  CAS  Google Scholar 

  107. Kalina, M., Kletter, Y., and Aronson, M., 1974, The interaction of phagocytes and the large-sized parasite Cryptococcus neoformanscytochemical and ultrastructural study, Cell. Tissue Res. 152:165–174.

    PubMed  CAS  Google Scholar 

  108. Aronson, M., and Kletter J., 1973, Aspects of the defense against a large-sized parasite, the yeast, Cryptococcus neoformans, in: Dynamic Aspects of Host Parasitic Relationships (D. Weiss and A. Zuckerman, eds.) Academic Press, New York, pp. 132–162.

    Google Scholar 

  109. Miller, G. P., and Kohl, S., 1983, Antibody-dependent leukocyte killing of Cryptococcus neoformans, J. Immunol. 131:1455–1459.

    PubMed  CAS  Google Scholar 

  110. Brummer, E., and Stevens, D. A., 1984, Activation of murine polymorphonuclear neutrophils for fungicidal activity with supernatants from antigen-stimulated immune spleen cell cultures, Infect. Immun. 45:447–452.

    PubMed  CAS  Google Scholar 

  111. Brummer, E., Sugar, A. M., and Stevens, D. A., 1985, Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity, Infect. Immun. 49:396–401.

    PubMed  CAS  Google Scholar 

  112. Djeu, J. Y., Blanchard, D. K., Halkias, D., and Friedman, H., 1986, Growth inhibition of Candida albicansby human polymorphonuclear neutrophils: Activation by interferon-α and tumor necrosis factor, J. Immunol. 137:2980–2984.

    PubMed  CAS  Google Scholar 

  113. Kagaya, K., and Fukazawa, Y., 1981, Murine defense mechanism against Candida albicansinfection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans, Microbiology 25:807–818.

    CAS  Google Scholar 

  114. Djeu, J. Y., Blanchard, D. K., and Friedman, H., 1987, Regulation of human polymorphonuclear neutrophil activity against Candida albicansby large granular lymphocytes via release of interferon, tumor necrosis factor and another unidentified cytokine, Lymphokine Res. 6:1414.

    Google Scholar 

  115. Murphy, J. W., and McDaniel, D. O., 1982, In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans, J. Immunol. 128:1577–1583.

    PubMed  CAS  Google Scholar 

  116. Murphy, J. W., and McDaniel, D. O., 1982, In vitro effects of natural killer (NK) cells on Cryptococcus neoformans, in: NK Cells and Other Natural Effector Cells (R. B. Herberman, ed.), Academic Press, New York, pp. 1105–1112.

    Google Scholar 

  117. Murphy, J. W., 1984, Natural killer cells against a mycotic pathogen, in: Microbiology—1984 (L. Leive and D. Schlessinger, eds.), American Society for Microbiology, Washington, pp. 328–332.

    Google Scholar 

  118. Murphy, J. W., 1985, Natural cell-mediated resistance against Cryptococcus neoformans. A possible role for natural killer (NK) cells, in: Current Topics in Medical Mycology, Volume 1 (M. R. McGinnis, ed.), Springer-Verlag, New York, pp. 135–154.

    Google Scholar 

  119. Nabavi, N., and Murphy, J. W., 1985, In vitro binding of natural killer cells to Cryptococcus neoformans targets, Infect. Immun. 50:50–57.

    PubMed  CAS  Google Scholar 

  120. Murphy, J. W., 1982, Natural cell-mediated resistance in cryptococcosis, in: NK Cells and Other Natural Effector Cells (R. B. Herberman, ed.), Academic Press, New York, pp. 1503–1511.

    Google Scholar 

  121. Hidore, M. R., and Murphy, J. W., 1986, Natural cellular resistance of beige mice against Cryptococcus neoformans, J. Immunol. 137:3624–3631.

    PubMed  CAS  Google Scholar 

  122. Hidore, M. R., and Murphy, J. W., 1986, Correlation of natural killer cell activity and clearance of Cryptococcus neoformansfrom mice after adoptive transfer of splenic nylon wool-nonadherent cells, Infect. Immun. 51:547–555.

    PubMed  CAS  Google Scholar 

  123. Lipscomb, M. F., Evans, Z. A., Toew, G. B., Hauff, N., Hackett, J., and Kumar, V., 1985, A role for natural killer (NK) cells in the clearance of intravenously injected Cryptococcus neoformans, Fed. Proc. 44:1084.

    Google Scholar 

  124. Lipscomb, M. F., Toews, G. B., Evans, Z., Tompkins, R., Alvarellos, T., and Kumar, V., 1986, A role for natural killer cells in murine cryptococcosis, 6th Int. Cong. Immunol. 5.16. 9:611.

    Google Scholar 

  125. Jimenez, B. E., and Murphy, J. W., 1984, In vitro effects of natural killer cells against Paracoccidioides brasiliensisyeast phase, Infect. Immun. 46:552–558.

    PubMed  CAS  Google Scholar 

  126. Tewari, R. P., Mkwananzi, J. B., McConnachie, P, Von Behren, L. A., Eagleton, L., Kulkarni, P., and Bartlett, P. C., 1981, Natural and antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood mononuclear cells (PBMC) to yeast cells of Histoplasma capsulatum(HC), ASM Abstr. F-66:324.

    Google Scholar 

  127. Yamada, T., Khardori, N., and Tewari, R. P., 1982, Natural and antibody-dependent cellular cytotoxicity (ADCC) of macrophages and lymphocytes from normal and immune mice for yeast cells of Histoplasma capsulatum (HC), ASM Abstr. F-9:328.

    Google Scholar 

  128. Petkus, A. F., and Baum, L. L., 1986, NK cell activity against Coccidioides immitis, Fed. Proc. 45:4516.

    Google Scholar 

  129. Zunino, S., and Hudig, D., 1986, Human NK lymphocytes do not kill Candida albicans, although Candida can block NK lysis of K562 cells, Nat. Immun. Cell Growth Regul. 5:166.

    Google Scholar 

  130. Baccarini, M., Bistoni, F., Puccetti, P., and Garaci, E., 1983, Natural cell-mediated cytotoxicity against Candida albicansinduced by cyclophosphamide: Nature of the in vitrocytotoxic effector, Infect. Immun. 42:1–9.

    PubMed  CAS  Google Scholar 

  131. Nabavi, N., and Murphy, J. W., 1986, Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans, Infect. Immun. 51:556–562.

    PubMed  CAS  Google Scholar 

  132. Kiessling, R., Klein, E., and Wigzell, H., 1975, “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype, Eur. J. Immunol. 5:112–117.

    PubMed  CAS  Google Scholar 

  133. Reynold, C. W., Timonen, T., and Herberman, R. B., 1981, Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells, J. Immunol. 127:282–287.

    Google Scholar 

  134. Djeu, J. Y., Heinbaugh, J. A., Holden, H. T., and Herberman, R. B., 1979, Role of macrophages in the augmentation of mouse natural killer cell activity by poly I:C and interferon, J. Immunol. 122:182–188.

    PubMed  CAS  Google Scholar 

  135. Djeu, J. Y., Heinbaugh, J. A., Viera, W. D., Holden, H. T., Herberman, R. B., 1979, The effect of immunopharmacologic agents on mouse natural killer cell-mediated cytotoxicity and its augmentation by poly I:C, Immunopharmacology 1:231–244.

    CAS  Google Scholar 

  136. Savary, C. A., and Lotzova, E., 1978, Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice, J. Immunol. 120:239–243.

    PubMed  CAS  Google Scholar 

  137. Ojo, E., Haller, O., Kimura, A., and Wigzell, H., 1978, An analysis of conditions allowing Corynebacterium parvumto cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice, Int. J. Cancer 21:444–451.

    PubMed  CAS  Google Scholar 

  138. Riccardi, C., Barlozzari, T., Santoni, A., Herberman, R. B., and Cesarini, C., 1981, Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors, J. Immunol. 126:1284–1289.

    PubMed  CAS  Google Scholar 

  139. Kozel, T. R., and Mastroianni, R. P., 1976, Inhibition of phagocytosis by cryptococcal polysaccaride: Dissociation of the attachment and ingestion phases of phagocytosis, Infect. Immun. 14:62–67.

    PubMed  CAS  Google Scholar 

  140. Timonen, T., Ortaldo, J. R., and Herberman, R. B., 1981, Characteristics of human large granular lymphocytes and relationship to natural killer and K cells, J. Exp. Med. 153:569–575.

    PubMed  CAS  Google Scholar 

  141. Bradley, T. P., and Bonavida, B., 1982, Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay, J. Immunol. 129:2260–2265.

    PubMed  CAS  Google Scholar 

  142. Kumagai, K., Itoh, K., Suzuki, R., Hinuma, S., and Saitoh, F., 1982, Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities, J. Immunol. 129:388–394.

    PubMed  CAS  Google Scholar 

  143. Ojo, E., and Wigzell, H., 1978, Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytotoxicity ability for antibody-coated tumor target cells, Scand. J. Immunol. 7:297–306.

    PubMed  CAS  Google Scholar 

  144. Wahlin, B., and Perlmann, P., 1983, Characterization of human K cells by surface antigens and morphology at the single cell level, J. Immunol. 131:2340–2347.

    PubMed  CAS  Google Scholar 

  145. Cauley, L. K., and Murphy, J. W., 1979, Response of congenitally athymic (nude) and phenotypically normal mice to a Cryptococcus neoformansinfection, Infect. Immun. 23:644–651.

    PubMed  CAS  Google Scholar 

  146. Marquis, G., Montplasir, S., Pelletier, M., Mousseau, S., and Auger, P., 1985, Genetic resistance to murine cryptococcosis: The beige mutation (Chediak-Higashi syndrome) in mice, Infect. Immun. 47:288–293.

    PubMed  CAS  Google Scholar 

  147. Salkowski, C. A., Bartizal, K. F., and Balish, E., 1985, Susceptibility of congenitally immunodeficient mice to Cryptococcus neoformans, in: Germfree Research: Microflora Control and Its Application to the Biomedical Sciences (B. W. Wostmann, ed.), Alan R. Liss, New York, pp. 407–410.

    Google Scholar 

  148. Bartizal, K. F., Salkowski, C. A., and Balsih, E., 1985, Modulation of murine natural killer cells by Cryptococcus neoformans, in Germfree Research: Microflora Control and Its Application to the Biomedical Sciences (B. W. Wostmann, ed.), Alan R. Liss, New York, pp. 333–336.

    Google Scholar 

  149. Henkart, P. A., 1985, Mechanism of lymphocyte-mediated cytotoxicity, Annu. Rev. Immunol. 3:31–58.

    PubMed  CAS  Google Scholar 

  150. Goldfarb, R. H., Timonen, T., and Herberman, R. B., 1983, Mechanism of tumor cell lysis by natural killer cells, in: NK Activity and Its Regulation (T. Hoshino, H. S. Koren, and A. Uchids, eds.), International Congress Series 641, Excerpta Medica, Amsterdam, pp. 403–421.

    Google Scholar 

  151. Roder, J. C., Kiessling, R., Biberfeld, P., and Anderson, B., 1978, Target-effector in¬teraction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing, J. Immunol. 121:2509–2517.

    PubMed  CAS  Google Scholar 

  152. Hiserodt, J. C., Britvan, L. J., and Targan, S. R., 1982, Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: Resolution into binding, programming and killer cell-independent steps, J. Immunol. 129:1782–1787.

    PubMed  CAS  Google Scholar 

  153. Hiserodt, J. C., and Beals, T. F., 1985, Ultrastructural analysis of human natural killer cell—target cell interactions leading to target cell lysis, in: Mechanisms of Cytotoxicity by NK Cells (R. B. Herberman and D. M. Callewaert, eds.), Academic Press, New York, pp. 195–204.

    Google Scholar 

  154. Henkart, M. P., and Henkart, P. A., 1982, Lymphocyte-mediated cytotolysis as a secretory process, in: Mechanisms of Cell-Mediated Cytotoxicity (W. R. Clark and R. Golstein, eds.), Plenum, New York, pp. 227–242.

    Google Scholar 

  155. Henkart, P., Millard, P., Yue, C., Fredrickse, P., Blumenthal, R., Bluestone, J., Rey¬nolds, C. W., and Henkart, M. P., 1985, Biochemical and functional properties of LGL and CTL cytoplasmic granules. Adv. Exp. Med. Biol. 184:121–134.

    PubMed  CAS  Google Scholar 

  156. Murphy, J. W., Reynolds, C. W., and Henkart, P. A., 1986, Effects of NK cell granules and cytolysin on Cryptococcus neoformans, Nat. Immun. Cell Growth Regul. 5:150.

    Google Scholar 

  157. Walters, M., Papadimitriou, J. M., and Robertson, T. A., 1976, The surface morphology of the phagocytosis of micro-organisms by peritoneal macrophages, J. Pathol. 118:221–226.

    PubMed  CAS  Google Scholar 

  158. Papadimitriou, J. M., Robertson, T. A., Kletter, Y., Aronson, M., and Walters, M. N.- I., 1978, An ultrastructural examination of the interaction between macrophages and Cryptococcus neoformans, J. Pathol. 124:103–109.

    PubMed  CAS  Google Scholar 

  159. Marconi, P., Scaringi, L., Tissi, L., Boccanera, M. Bistoni, F., Bonmassar, E., and Cassone, A., 1985, Induction of natural killer cell activity by inactivated Candida albicansin mice, Infect. Immun. 50:297–303.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Botany and Microbiology, University of Oklahoma, Norman, Oklahoma, 73019, USA

    Juneann W. Murphy

Authors
  1. Juneann W. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Frederick Cancer Research Facility, National Cancer Institute, Frederick, Maryland, USA

    Robert H. Wiltrout

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Murphy, J.W. (1989). Natural Host Resistance Mechanisms against Systemic Mycotic Agents. In: Reynolds, C.W., Wiltrout, R.H. (eds) Functions of the Natural Immune System. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0715-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0715-0_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8046-0

  • Online ISBN: 978-1-4613-0715-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation